The Lancet Oncology · 2016 · 283 citations · 17 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyUrologic OncologyGenitourinary Cancer PharmacotherapyMetastatic Cancer ManagementMetastatic Disease ManagementMetastatic Disease TreatmentProstate CancerToxicity ManagementAdvanced Prostate Cancer TherapyBicalutamide MonotherapyChemotherapy For Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer Hormonal Therapy
17
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +17
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran, Samedy Ouk, Nicola J. Clegg et al. · Science · 2009 · 2.3K citations · Full text